Jorge Cortes, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novartis
    Topic:
    CML, AML
    Date added:
    03/14/2023
    Date updated:
    04/08/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Pfizer
    Topic:
    CML, AML, ALL
    Date added:
    03/14/2023
    Date updated:
    04/08/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Takeda
    Topic:
    CML
    Date added:
    03/14/2023
    Date updated:
    04/08/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Abbvie
    Topic:
    AML, MPN
    Date added:
    03/14/2023
    Date updated:
    04/08/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Sun Pharma
    Topic:
    CML
    Date added:
    03/14/2023
    Date updated:
    04/08/2024
Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice